Clinical Trial

Inter-Device Concordance of Plantar Thermal Asymmetry Measurement (HIK-DM-2026)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This cross-sectional observational study measures the inter-device concordance between two infrared thermographic cameras, a low-cost model (HIKMICRO Mini2 V2) and a high-resolution model (HIKMICRO M60), when measuring plantar skin temperature in adults with diabetes mellitus. Each participant undergoes two consecutive thermographic acquisitions, always less than 10 seconds apart, from a fixed tripod at 75 cm, under standardized environmental conditions. The order of the two cameras is randomized 1:1 at participant level (sequence A: M60 then Mini2 V2; sequence B: Mini2 V2 then M60). The primary endpoint is the agreement between the two devices for contralateral thermal asymmetry (Delta T) in each of six pre-specified plantar regions of interest (ROIs), quantified by the intraclass correlation coefficient (ICC) for absolute agreement, with the consistency ICC for mean plantar temperature (Tmean) as an exploratory endpoint. The study is strictly metrological. Neither camera is a medical device under Regulation (EU) 2017/745, no clinical decision is derived from the measurements, and the study does not evaluate the detection, diagnosis, screening or prevention of any disease. Neither device is designated as a diagnostic reference standard. Participants with diabetes mellitus are included solely because plantar thermal variability is greater in this population, which makes the inter-device comparison metrologically demanding.
Protocol Amendment History 4 changes
critical Primary endpoint(s) modified 2026-08-07
notable Sponsor changed: Universidad Europea de Canarias -> Eduardo Luis Martín Javier 2026-08-07
notable Primary completion pushed: 2026-10 -> 2027-04 2026-08-07
minor Completion pushed: 2026-12 -> 2027-07 2026-08-07
Trial Details
NCT Number NCT07463456
Lead Sponsor Eduardo Luis Martín Javier
Conditions Diabetes Mellitus
Enrollment 130 participants
Start Date 2026-10
Primary Completion 2027-04 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-06